BRCA1 and neoplasm: This issue is particularly relevant in HGOC patients, in whom the prevalence of germline BRCA1/2 PVs is estimated to be as high as 10–15%10,22,23, but it could also affect other BRCA-associated tumours, including advanced prostate cancer24.